Nimbus Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
130 Prospect St Ste 301, Cambridge, Mass...Phone Number
(857) 999-2009Website
www.nimbustx.comRevenue
$16.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nimbus Therapeutics
Nimbus Therapeutics specializes in the design and development of highly selective small molecule medicines aimed at improving patient outcomes in oncology, immunology, and metabolic diseases. The company employs advanced computational drug design and a meticulous approach to target selection, ensuring their products are both effective and innovative. With a strong track record of success, Nimbus is committed to pushing the boundaries of medicine through cutting-edge technologies and world-class expertise. Their intended clients include patients in need of novel treatments and healthcare partners seeking collaboration in drug development.Explore more
Nimbus Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nimbus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nimbus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Nimbus Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Nimbus Therapeutics has new funding data
Check out if Nimbus Therapeutics is spiking on competitors!
Click to see if Nimbus Therapeutics had a recent Job posting/layoffs
Check if Nimbus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Nimbus Therapeutics
Earning: See what the market has to say on Nimbus Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Nimbus Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Nimbus Therapeutics
Compare insights from companies similar to Nimbus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nimbus Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nimbus Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nimbus Therapeutics.
Nimbus Therapeutics financials insights
Gather financial insights about Nimbus Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$1.5M
Series A
$24M
2015
Series B
$43M
2018
Unspecified
$65M
2020
Private Equity
$60M
2021
Private Equity
$105M
2022
Other Financing Round
$125M
2023
Other Financing Round
$210M
Nimbus Therapeutics Tech Stack
A closer look at the technologies used by Nimbus Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals, Artificial Intelligence
Person-Based
Product Development, Pharmaceuticals, Artificial Intelligence
Person-Based
Pharmaceuticals, Artificial Intelligence
Person-Based
Person-Based
Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nimbus Therapeutics
Sign Up For FreeTo access detailed company insights
Nimbus Therapeutics specializes in the design and development of highly selective small molecule medicines aimed at improving patient outcomes in oncology, immunology, and metabolic diseases. The company employs advanced computational drug design and a meticulous approach to target selection, ensuring their products are both effective and innovativ... Read More
